NCT06466746

Brief Summary

High levels of animal proteins (meat) in the diet are linked with a greater risk of developing heart disease and other long-term health conditions. Recently there has been a shift to plant-based diets including plant proteins such as pulses, defined as beans, peas, chickpeas and lentils. Pulses are a nutritious and sustainable form of plant protein which are rich in fibre and iron. Despite this, the UK population does not consume the recommended daily amount of pulses (80g/day equivalent to a large handful). In contrast, bread is commonly consumed but very little is known about how bread enriched with pulses influences the amount of iron that is digested and absorbed by the body as well as risk factors for developing heart disease and type 2 diabetes. The main purpose of this randomised controlled cross-over study is to determine how consuming bread enriched with pulses (in the form of faba bean flour at approximately 40% enrichment) compared with conventional white bread (100% wheat flour) influences the amount of iron absorbed in healthy males and females aged 18-50 years with low iron stores. Secondary aims are determining the effects on blood fats and sugar (glucose) and on feelings of fullness (also known as satiety) after eating the bread enriched in pulses and conventional white bread. Participants will be required:

  • To attend for seven study visits over a period of 60 days.
  • Consume a breakfast meal containing either the faba bean-enriched bread or conventional bread over two study periods, each consisting of one 7 hour study visit and two consecutive visits of 2 hours in duration. After 28 days, participants will return for the second study period as above, with a final study visit conducted 28 days later.
  • Give blood samples during 2 x 7 hour study visits
  • Complete visual analogue scales to rate appetite after consuming the faba bean-enriched and conventional white bread.
  • Record dietary intake prior to and during the study period.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
16

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 4, 2024

Completed
16 days until next milestone

First Posted

Study publicly available on registry

June 20, 2024

Completed
2 months until next milestone

Study Start

First participant enrolled

September 1, 2024

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2025

Completed
Last Updated

September 19, 2024

Status Verified

September 1, 2024

Enrollment Period

9 months

First QC Date

June 4, 2024

Last Update Submit

September 11, 2024

Conditions

Keywords

faba bean enriched breadbioavailabilityEnrichment of blood haemoglobin with Iron-57 stable isotopePostprandial LipaemiaSatietyVisual analogue scalesPostprandial glycaemia

Outcome Measures

Primary Outcomes (1)

  • Change from baseline in the enrichment of whole blood haemoglobin with iron-57 stable isotope 30 days after consuming the faba bean-enriched bread and conventional bread.

    The measurement of iron-57 in whole blood is a validated method for determining the absorption of iron from the bread given in the test meals (also known as bioavailability)

    Day 0 (baseline), day 30 and day 60

Secondary Outcomes (28)

  • Fasting concentrations of iron status markers

    Day 0 (baseline), day 30 and day 60

  • Fasting concentration of C-reactive protein (a marker of inflammation)

    Day 0 (baseline), day 30 and day 60

  • Fasting levels of the full blood count parameters

    Day 0 (baseline), day 30 and day 60

  • Fasting concentration of total cholesterol, high-density lipoprotein-cholesterol, triacylglycerol and non-esterified fatty acids.

    Day 0 (baseline), day 30 and day 60

  • Fasting low-density lipoprotein-cholesterol concentration

    Day 0 (baseline), day 30 and day 60

  • +23 more secondary outcomes

Study Arms (2)

Faba bean-enriched bread.

ACTIVE COMPARATOR

100 g of bread prepared using 40% faba bean flour and 60% wheat flour will be provided in the breakfast test meal.

Other: Raising the Pulse faba bean-enriched bread

Conventional white bread

PLACEBO COMPARATOR

100 g of white bread prepared using 100% wheat flour will be provided in the breakfast test meal.

Other: Conventional White Bread

Interventions

100 g of white bread produced using 40% faba bean enriched flour and 60% wheat flour will be provided in the breakfast meal with stork margarine, chocolate spread, a glass of orange juice and a glass of water containing the iron-57 stable isotope. An ad-libitum lunch consisting of pasta and a tomato sauce will be provide 6 hours after the breakfast.

Faba bean-enriched bread.

100 g of white bread produced using 100% wheat flour will be provided in the breakfast meal with stork margarine, chocolate spread, a glass of orange juice and a glass of water containing the iron-57 stable isotope. An ad-libitum lunch consisting of pasta and a tomato sauce will be provide 6 hours after the breakfast.

Conventional white bread

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Non-anaemic, males and pre-menopausal females (must have regular periods)
  • Aged 18-50 years old
  • BMI between 19 - 30 kg/m2
  • Low iron stores (serum ferritin between 13-40 µg/L for females and 30-90 µg/L for males)

You may not qualify if:

  • Food allergies or intolerances to faba beans (favism) or gluten
  • Diagnosed with anaemia (haemoglobin \<115 g/L for females or \<130 g/L for males) or haemochromatosis
  • C-reactive protein (\>3mg/L)
  • Smokers
  • A history of alcohol abuse (\> 14 units/ week)
  • CVD or medical history of MI or stroke in the past 12 months
  • Diabetes (fasting glucose \>7.0 mmol/L)
  • Kidney, liver, pancreas or intestinal disease, gastrointestinal disorder or use of drugs likely to alter gastrointestinal function
  • Pregnancy, planning a pregnancy in the next six months or breastfeeding
  • Peri- and post-menopausal women or women with irregular periods
  • Planning on a weight-reducing regimen (lost \>3kg in last 6 months)
  • Parallel participation in another intervention study
  • Hypertension (blood pressure \> 140/90 mmHg), cancer, taking medication for hyperlipidaemia (statins), or inflammation
  • Taking vitamin or mineral supplements
  • Donated blood in the last 3 months
  • +1 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hugh Sinclair Unit of Human Nutrition, Department of Food and Nutritional Sciences, University of Reading

Reading, Berkshire, RG6 6AP, United Kingdom

RECRUITING

Related Publications (1)

  • Lovegrove JA, O'Sullivan DM, Tosi P, Millan E, Todman LC, Bishop J, Chatzifragkou A, Clegg ME, Hammond J, Jackson KG, Jones PJ, Lignou S, Macready AL, McMeel Y, Parker J, Rodriguez-Garcia J, Sharp P, Shaw LJ, Smith LG, Tebbit M. 'Raising the Pulse': The environmental, nutritional and health benefits of pulse-enhanced foods. Nutr Bull. 2023 Mar;48(1):134-143. doi: 10.1111/nbu.12601. Epub 2023 Jan 17.

    PMID: 36649740BACKGROUND

MeSH Terms

Conditions

Anemia, Iron-Deficiency

Condition Hierarchy (Ancestors)

Anemia, HypochromicAnemiaHematologic DiseasesHemic and Lymphatic DiseasesIron DeficienciesIron Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Study Officials

  • Abbe Davy, BSc

    University of Reading

    STUDY DIRECTOR

Central Study Contacts

Julie A Lovegrove, BSc PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Human Nutrition and Director of the Hugh Sinclair Unit of Human Nutrition

Study Record Dates

First Submitted

June 4, 2024

First Posted

June 20, 2024

Study Start

September 1, 2024

Primary Completion

June 1, 2025

Study Completion

September 1, 2025

Last Updated

September 19, 2024

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will share

All anonymised IPD that underlie results in a publication and analytic code for the statistical analysis.

Shared Documents
STUDY PROTOCOL, ANALYTIC CODE
Time Frame
Anonymised data will be made available on reasonable request one year after manuscripts have been published.
Access Criteria
For data sharing and preservation, anonymised IPD will be archived in the University of Reading Research Data Archive. Access will be overseen by the project PI. This information will be maintained under Professor Julie Lovegrove's and Dr Kim Jackson's authority and disposed of appropriately by the PI \[Professor Julie Lovegrove\]. If the PI should leave the University, the Personal Information will be under the authority of the Head of School.

Locations